This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, Loma Linda University, Wake Forest University. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
4 out of 3,697 
3 out of 235 
3 out of 524 
Years Active: 2015-2017
Title: The Innovative Journey of Richard O Cannon, III: Advancing Cardiovascular Treatments
Introduction: Richard O Cannon, III, based in Potomac, MD, is a remarkable inventor known for his contributions to the field of cardiovascular medicine. With a total of four patents to his name, Cannon has made significant strides in improving health outcomes for individuals with various cardiovascular conditions.
Latest Patents: Among Cannon's latest innovations is his patent regarding the use of nitrite salts for the treatment of cardiovascular conditions. His research has uncovered that the administration of nitrite can lead to a reduction in blood pressure and an enhancement of blood flow, particularly beneficial for tissues experiencing low oxygen levels. This groundbreaking discovery paves the way for effective treatments aimed at managing a patient's blood pressure and improving blood flow through the administration of pharmaceutically acceptable nitrite salts. The patent details methods for treating or alleviating conditions such as ischemia-reperfusion injury, pulmonary hypertension, and cerebral artery vasospasm.
Career Highlights: Over the years, Richard O Cannon, III has collaborated with notable institutions such as the United States Department of Health and Human Services and Wake Forest University. His work in these esteemed organizations has highlighted his commitment to advancing medical research and finding innovative solutions to complex health issues.
Collaborations: Cannon's journey has been enriched by working alongside esteemed colleagues, including Alan N Schechter and Christian J Hunter. These collaborations have not only facilitated knowledge sharing but have also contributed to the successful development of transformative medical technologies.
Conclusion: Richard O Cannon, III continues to be a driving force in the realm of cardiovascular innovation. His inventive spirit and research prowess exemplify the critical role of inventors in shaping the future of healthcare, particularly for those afflicted with cardiovascular ailments. As he forges ahead with his work, the medical community eagerly anticipates the potential impacts of his discoveries on patient care and outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile